AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2025
Sep 3, 2025
30591_dirs_2025-09-03_f8be8650-a826-4e18-95e0-4308751e3f22.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2025-08-29
Reporting Person: Geary Richard S (EVP, Chief Development Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-29 | Common Stock | J | 165 | $27.71 | Acquired | 89657 | Direct |
Footnotes
F1: Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 29, 2025. These shares may not be sold until March 2, 2026.
More from IONIS PHARMACEUTICALS INC
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 24